Sanofi-Aventis May Be First In Wave Of National Pharma; Will Swiss Follow?

Sanofi-Synthelabo's merger with Aventis may be the first in a trend towards the creation of national pharma companies that could include the formation of "Pharma Swiss," according to Wood Mackenzie VP-Life Sciences Clifford Kalb